[RNAZ] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[RNAZ] TransCode Therapeutics, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 7.44%
YoY- -86.52%
Quarter Report
RNAZ's Result
RNAZ's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -4,342 -4,817 -5,134 -4,290 -4,671 -3,470 -5,910 -18.62%
Tax 789 -5 13,275 655 -36 -7 2,924 -58.34%
NP -4,342 -4,812 -18,409 -4,290 -4,635 -3,463 -8,834 -37.80%
Tax Rate - - - - - - - -
Total Cost 4,342 4,812 18,409 4,290 4,635 3,463 8,834 -37.80%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -135.68 -267.34 -1,134.84 -264.45 -289.70 -216.41 -552.15 -60.86%
EPS Diluted -131.61 -267.34 -1,134.84 -264.45 -285.73 -213.45 -547.70 -61.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.